Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Usability of the Inga Catheter for Labor Induction (INGA-MDP)

The goal of this clinical study is to evaluate a new mechanical balloon catheter (INGA) used to prepare the cervix for labor induction in pregnant women at term. The study aims to assess the safety, usability, and performance of the INGA catheter when used for cervical ripening before labor. Researchers will also collect feedback from healthcare professionals and participants about the use of the device. Participants are pregnant women at term with a single baby in a head-down position who meet the study eligibility criteria. Participants will: * have the INGA balloon catheter inserted as part of labor induction, * receive standard clinical care according to hospital practice, * provide information about their experience and outcomes related to the device. The results of this study will help determine whether the INGA catheter is safe and suitable for use in cervical ripening during labor induction.

Participants needed: 45
Trial details
Age: 18-56Biological sex: FemaleType: InterventionalSponsor: Aalto UniversityUpdated: May 26, 2026Locations: 3
Eligibility criteria

Pregnant women aged ≥18 and ≤56 years [+13]

Preterm induction of labor (<37 weeks of gestation) [+16]

Status: Not yet recruiting

Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction

This study investigates the safety and usability of the new INGA catheter for labor induction. Labor induction is common, with about one in three births being induced. In this study, the INGA catheter will be compared to a currently used method. The INGA catheter is a single-balloon device that works similarly to a Foley catheter but is made from different materials. Feedback will be collected from both healthcare professionals and participating women.

Participants needed: 40
Trial details
Age: 18-56Biological sex: FemaleType: InterventionalSponsor: Aalto UniversityUpdated: May 27, 2026
Eligibility criteria

Pregnant women aged ≥18 and ≤56 years [+6]

Preterm induction of labor (<37 weeks of gestation) [+19]

Status: Not yet recruiting

Evaluation of the INGA Sensor System for Fetal and Uterine Monitoring During Cervical Ripening

The goal of this clinical trial is to learn about the safety and performance of the INGA Sensor System when used with the INGA balloon catheter during cervical ripening for labor induction in pregnant individuals at term. Cervical ripening is a process used to prepare the cervix for labor. The main questions it aims to answer are: * Is the INGA Sensor System safe to use during cervical ripening with the INGA balloon catheter? * How well does the sensor system measure uterine contractions and fetal heart rate during cervical ripening? * How does the use of the INGA balloon catheter affect cervical ripening and the time from induction to delivery? * How do participants and healthcare professionals evaluate the usability of the catheter and sensor system? All participants in this study will receive the INGA balloon catheter with the attached sensor system. There is no comparison group. Participants will: * Undergo routine assessments before labor induction, including medical history review, cervical examination, blood pressure and heart rate measurement, and fetal heart rate monitoring * Have the INGA balloon catheter placed in the cervix by a trained physician * Have a small sensor device attached to the external end of the catheter * Undergo standard fetal heart rate monitoring after placement * Keep the catheter and sensor in place until the catheter is expelled naturally or for up to 24 hours * Continue labor induction and delivery according to standard hospital practice * Complete a questionnaire about comfort and usability * Allow collection of information about labor, delivery, and newborn outcomes from medical records Participation lasts from signing informed consent until hospital discharge.

Participants needed: 120
Trial details
Age: 18-56Biological sex: FemaleType: InterventionalSponsor: Aalto UniversityUpdated: Feb 25, 2026
Eligibility criteria

Preterm induction of labor (<37 weeks of gestation) [+19]